Teladoc expands Microsoft tie-up to document patient visits with AI
Reuters
Published Jul 18, 2023 08:37AM ET
Updated Jul 18, 2023 02:10PM ET
(Reuters) - Teladoc (NYSE:TDOC) Health is expanding a partnership with Microsoft (NASDAQ:MSFT) to use the tech giant' s artificial intelligence services to automate clinical documentation on the telehealth platform, lifting its shares 6% in premarket trade.
The integration of AI including Microsoft's services with technology from OpenAI, owner of viral chatbot ChatGPT, will help ease the burden on healthcare staff during virtual exams, Teladoc said on Tuesday.
The companies have been collaborating since the height of the COVID-19 pandemic in 2021, when Teladoc integrated its Solo virtual healthcare platform into Microsoft Teams.
Teladoc will now also use Microsoft's Nuance Dragon Ambient eXperience, an AI-powered voice-enabled solution that uses the GPT4 AI service, to automatically document patient encounters for final review and signoff by clinicians.
"Administrative burden and staff shortages are major reasons why clinicians are leaving the profession," Teladoc's chief medical officer, Vidya Raman-Tangella, said in a statement.
The use of AI is being actively discussed by hospitals and other healthcare providers that suffered from attrition caused by pandemic fatigue. Industries across the board have been looking at integrating AI into their businesses, after the launch of OpenAI's ChatGPT in November fueled interest in the breakthrough technology.
(This story has been corrected to say that Microsoft does not own OpenAI in paragraph 2)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.